Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02096198 · ClinicalTrials.gov registry record

Ceramic On Ceramic (COC) 36mm PAS IDE Rollover Subjects; Ceramic Acetabular Bearing With Ceramic Femoral Head in Total Hip Replacement

A clinical trial of Osteoarthritis and Avascular Necrosis, sponsored by DePuy Orthopaedics.

Completed
Registry status
81
Enrollment target
5
Study locations

NCT02096198 is a study of Osteoarthritis and Avascular Necrosis that has completed, run by DePuy Orthopaedics. The registered enrollment target is 81 participants, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (90% lower). The trial reports 5 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02096198, a study of Osteoarthritis and Avascular Necrosis, has completed, sponsored by DePuy Orthopaedics.

COMPLETED
Registry status
81 participants
Enrollment target
5
Study locations

Study Summary

This study is intended to gather medium (5- to 7-years) and long-term (minimum 8- to 10-years) information regarding the performance and safety of the commercially available 36mm CERAMAX® Ceramic on Ceramic (COC) Total Hip System from a cohort of study subjects that were previously enrolled in the IDE study. (COC = 36mm ceramic acetabular bearing insert component that articulates with a ceramic femoral head in the COC total hip replacement system)

Study Locations (5)

California

  • - Sacramento

Colorado

  • - Denver

North Carolina

  • - Winston-Salem

Ohio

  • Orthopedic One - Columbus

Virginia

  • - Alexandria

Trial Details

FieldValue
Enrollment Target 81 participants
Start Date 2014-01-01
Est. Completion 2018-08-20

Sponsor

DePuy Orthopaedics

38 total trials

What the Registry Record Tells You About NCT02096198

The ClinicalTrials.gov registry entry for NCT02096198 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (90% lower). The listed sponsor is DePuy Orthopaedics, which has 38 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Osteoarthritis appearing as the primary indexed condition, and to 0 interventions.

NCT02096198 reports 5 study locations spanning 5 distinct geographic areas - top geographies include California, Colorado, North Carolina.

Frequently Asked Questions

What is clinical trial NCT02096198 about?

NCT02096198 is a clinical study titled "Ceramic On Ceramic (COC) 36mm PAS IDE Rollover Subjects; Ceramic Acetabular Bearing With Ceramic Femoral Head in Total Hip Replacement". This study is intended to gather medium (5- to 7-years) and long-term (minimum 8- to 10-years) information regarding the performance and safety of the commercially available 36mm CERAMAX® Ceramic on Ceramic (COC) Total Hip System from a cohort of study subjects that were previously enrolled in the I...

What is the current status of trial NCT02096198?

This trial is currently completed. The enrollment target is 81 participants. The study started on 2014-01-01. Estimated completion is 2018-08-20.

What conditions does trial NCT02096198 study?

This clinical trial studies the following conditions: Osteoarthritis, Avascular Necrosis, Non-inflammatory Degenerative Joint Disease, Post-Traumatic Osteoarthritis of Hip.

Who is sponsoring clinical trial NCT02096198?

This trial is sponsored by DePuy Orthopaedics, which has 38 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02096198 being conducted?

This trial has 5 study locations across California, Colorado, North Carolina, Ohio, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Osteoarthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.